(NASDAQ: KPRX) Clinical development-stage pharmaceutical company focusing on novel therapeutics for treatment of orphan retinal diseases with high unmet need.

ID: 902556763198812160

linkhttps://kiorapharma.com/ calendar_today29-08-2017 15:41:15